Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Citado por Google
- Similares em SciELO
- Similares em Google
Compartilhar
Acta Medica Colombiana
versão impressa ISSN 0120-2448
Resumo
MEJIA-OCHOA, Monica; ACEVEDO-TORO, Paola Andrea e CARDONA-ARIAS, Jaiberth Antonio. Meta-analysis of the frequency of JAK2 in primary myelofibrosis according to the detection method used. Acta Med Colomb [online]. 2020, vol.45, n.4, pp.41-47. Epub 11-Jun-2021. ISSN 0120-2448. https://doi.org/10.36104/amc.2020.1462.
Background and objective:
in the global scientific literature, the frequency of JAK2 is highly heterogenous in chronic myeloproliferative neoplasms. The objective of this study was to analyze the prevalence of the JAK2 mutation in primary myelofibrosis (PMF) and compare it according to the detection method used, from 2007-2018.
Materials and methods:
a systematic review with meta-analysis, using 21 searches in three multidisciplinary databases. The PRISMA guideline phases of identification, screening, selection and inclusion were applied. Reproducibility and evaluation of the methodological quality were ensured. The analyses were based on frequencies and meta-analysis for the prevalence of the mutation with its 95% confidence interval.
Results:
twenty-nine studies with 744 patients were included, mainly from Korea, Brazil and China. The most commonly used technique was AS-PCR, and the prevalence of JAK2 with this technique ranged from 33.3 to 71.4%; with real-time PCR ranging from 42.9 to 77.3%, sequencing from 14.3-57.4%, and ARMS from 36.4-83.3%. The prevalence of JAK2 showed no statistically significant differences according to the type of diagnostic test used.
Conclusion:
high frequencies of the JAK2V617F mutation are seen in PMF, which shows that this entity should not be diagnosed solely based on clinical and hematological characteristics, but also on the patients' genetic screening.
Palavras-chave : prevalence; mutation; JAK2; primary myelofibrosis; meta-analysis.